Cancer News and Research

Latest Cancer News and Research

TWi Biotech enrolls over 50% of patients for AC-201 Phase IIb trial against Type II Diabetes

TWi Biotech enrolls over 50% of patients for AC-201 Phase IIb trial against Type II Diabetes

Calcium-sensing receptor plays key role in lethal lung cancer complication

Calcium-sensing receptor plays key role in lethal lung cancer complication

CTI completes pixantrone NDA resubmission meeting with FDA's Division of Oncology Drug Products

CTI completes pixantrone NDA resubmission meeting with FDA's Division of Oncology Drug Products

JEM published paper identifies new gene mutations in patients with chronic lymphocytic leukemia

JEM published paper identifies new gene mutations in patients with chronic lymphocytic leukemia

Researchers discover genetic factor that can regulate obesity-induced inflammation

Researchers discover genetic factor that can regulate obesity-induced inflammation

Orexo completes first OX27 pharmacokinetic trial against breakthrough pain in cancer

Orexo completes first OX27 pharmacokinetic trial against breakthrough pain in cancer

FDA approves Cornell Dots for first-in-human clinical trial for treatment of cancer

FDA approves Cornell Dots for first-in-human clinical trial for treatment of cancer

Perceived racism linked to elevated risk of self-reported sleep disturbance

Perceived racism linked to elevated risk of self-reported sleep disturbance

Colonoscopies done with suboptimal bowel preparation linked to high adenoma miss rates

Colonoscopies done with suboptimal bowel preparation linked to high adenoma miss rates

Life Technologies, Fox Chase partner to provide next-generation sequencing analysis of solid tumors

Life Technologies, Fox Chase partner to provide next-generation sequencing analysis of solid tumors

Researchers find how collagen production helps drive tumour growth, development

Researchers find how collagen production helps drive tumour growth, development

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Viewpoints: Private vs. public Medicare; N.J. Medicaid tough choices; IPAB's cost controls

Viewpoints: Private vs. public Medicare; N.J. Medicaid tough choices; IPAB's cost controls

Study explores age differences in barriers to cervical cancer screening attendance

Study explores age differences in barriers to cervical cancer screening attendance

Roundup: States controlled by GOP pass sweeping changes; state budgets still very lean from recession; La. Gov. wrestling with legislature over spending

Roundup: States controlled by GOP pass sweeping changes; state budgets still very lean from recession; La. Gov. wrestling with legislature over spending

Australian men unhealthy and unwilling to seek help: Report

Australian men unhealthy and unwilling to seek help: Report

Formaldehyde & other chemicals declared carcinogenic: Report

Formaldehyde & other chemicals declared carcinogenic: Report

Oncogene Aurora A may contribute to polycystic kidney disease

Oncogene Aurora A may contribute to polycystic kidney disease

Policy issues related to dual-eligible patients, cancer medication coverage attract headlines

Policy issues related to dual-eligible patients, cancer medication coverage attract headlines

Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia

Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.